Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2020 Earnings

6AugConfirmed

Q4 2019

Q1 2020

Q2 2020

Q3 2020

-11

-9.9

-8.81

-7.71

Details

Expected EPS

-9.063294999999998

Actual EPS

-8.316906

Surprise EPS

0.75

Surprise Percent

+8.24%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -8.316906 per share for Q3 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.